KSPI · DEEP VALUE BRIEFING

Joint Stock Company Kaspi.kz (KSPI)

published Oct 22, 2026 · price now $89.91 · market cap $17.1B

OPTIMISTIK · low confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

Kaspi appears to be a profitable, high-return local ecosystem priced for substantial country, currency, credit, and governance risk. At $93.51 and 8.52× earnings, the market is not demanding heroic growth, while 41.5% ROE, 9.3% ROA, and 43.6% reported revenue growth support the case for a genuine franchise rather than a merely cheap lender.

The principal uncertainty is earnings quality: distributable owner earnings, credit metrics, regulatory capital, and acquisition economics are not provided. Therefore, the low P/E cannot be treated as a complete margin-of-safety calculation. Still, there is no supplied evidence of distress or permanent business impairment.

Retain the original plan, but keep implementation conservative: initiate a small, staged position, not a full allocation. Fundamentals—not moving averages or options activity—should govern subsequent purchases.

Key Arguments from the Debate

Risky analyst: the valuation-growth mismatch supports immediate participation

The strongest bullish points are:

  • Kaspi combines payments, commerce, transfers, merchant infrastructure, data, and lending in one ecosystem.
  • Its 9.3% ROA makes it less likely that the 41.5% ROE is solely a product of leverage.
  • Implied EPS is approximately $10.97, making the current valuation unusually compressed relative to reported growth.
  • The stock remains 11.8% above its 200-day average, so recent weakness does not establish structural deterioration.
  • Elevated put open interest may include hedging and is not a reliable standalone directional signal.

This analyst is right that demanding complete certainty would likely mean paying a higher price later. The earlier KSPI review showed that persistent emerging-market risks should influence sizing without automatically blocking participation.

However, the suggested 12–15× rerating values of $132–$165 are not sufficiently grounded. They assume both durable EPS and a reduction in Kaspi’s risk discount. That is upside analysis, not a conservative intrinsic-value estimate.

Safe analyst: reported earnings may overstate distributable value

The strongest cautions are:

  • Revenue growth is not separated into organic, acquisition, inflation, and currency components.
  • Lending can absorb earnings through reserves, regulatory capital, liquidity, and funding requirements.
  • ROIC, nonperforming loans, cost of risk, reserve coverage, and capital adequacy are unavailable.
  • Kazakhstan concentration creates correlated exposure to currency weakness, funding pressure, regulation, consumer credit, and governance.
  • International expansion consumes real capital and should not be valued as free optionality.
  • The options market is cautionary, even if its directional meaning is ambiguous.

These are legitimate risk controls. In particular, applying an arbitrary 80% conversion rate to accounting EPS is not a reliable substitute for owner earnings in a financial-platform hybrid.

The safe analyst nevertheless overreaches by treating missing information almost like adverse evidence. No supplied data show that credit quality, solvency, or the domestic franchise is currently breaking down. Under the stated framework, uncertainty warrants a smaller allocation; it does not automatically warrant inaction.

Neutral analyst: participate, but cap exposure until economics are verified

This is the best implementation argument:

  • Positive expected value may exist, but the valuation distribution is unusually wide.
  • Technical and options data should affect entry pacing, not determine the investment thesis.
  • A 0.5%–0.75% initial position, with a provisional cap around 1.25%–1.5% and a hard ceiling near 2%, balances participation with capital preservation.
  • Additional purchases should follow evidence of stable credit quality, distributable earnings, and disciplined international investment.

That approach correctly translates uncertainty into position sizing rather than paralysis.

Risk Judgment

Business quality: promising, but not fully proven

Kaspi likely possesses meaningful local network effects:

  • Consumers attract merchants and product availability.
  • Merchants reinforce consumer convenience and transaction volume.
  • Transaction history supports underwriting, fraud detection, personalization, and cross-selling.
  • Integrated payments, commerce, and financing can create habitual use even without contractual switching costs.

These advantages appear economically meaningful given the reported returns on assets and equity. Nevertheless, the moat should be described as strong locally, not unquestionably wide and transferable. Multi-homing is possible, regulators can mandate interoperability or constrain fees, and foreign expansion may require rebuilding merchant density, logistics, trust, and underwriting data.

Financial risk: uncertainty, not demonstrated distress

The available figures do not trigger the framework’s hard distress floor. There is no evidence provided of:

  • interest coverage below 1×,
  • an Altman-Z distress condition,
  • collapsing profitability,
  • or simultaneous deterioration in fundamentals and solvency.

But the dataset is insufficient to establish strong financial safety because lending-related information is missing. The most important unknowns are:

  • nonperforming loans and delinquencies,
  • cost of risk and reserve coverage,
  • funding costs and liquidity,
  • regulatory capital,
  • and the proportion of earnings that can be distributed without weakening growth or solvency.

The appropriate classification is therefore material but unconfirmed financial risk, not proven impairment.

Valuation: attractive, with a wide confidence interval

At 8.52× earnings, the market already embeds substantial skepticism. Reported growth can decelerate sharply without necessarily invalidating the investment case.

However, the P/E ratio is not itself the margin of safety. For this business, intrinsic value depends on normalized credit losses, required capital retention, currency translation, and returns on international investment.

The supplied $105–$120 base range implies approximately 12%–28% upside. That is adequate for a small position in a high-return franchise, but not enough for concentration given the $60–$75 stress range, representing roughly 20%–36% downside. The low end of the base range offers only a modest quality-scaled discount.

The investment case should therefore rest on conservative compounding from present earnings—not an assumed rerating to a platform multiple.

Market signals: secondary and mixed

The stock is:

  • 0.9% below its 10-day EMA,
  • 5.0% below its 50-day SMA,
  • but 11.8% above its 200-day SMA.

This resembles near-term weakness within a still-improved longer-term structure, not a confirmed breakdown. Elevated put open interest indicates concern, but it may include hedges; call-heavy volume is also inconclusive without trade-direction data.

These signals support staging the entry. They do not override intrinsic-value analysis. A break below the 200-day average would become more important if accompanied by falling estimates, deteriorating credit, or weaker capital generation.

Refined Investor Plan

The original plan was to initiate a smaller-than-normal position rather than remain entirely on the sidelines. Retain that plan, but formalize the limits and confirmation requirements.

Initial allocation

  • Start with approximately 0.5%–0.75% of portfolio value.
  • Use two or three tranches rather than one purchase.
  • Keep the provisional allocation around 1.25%–1.5%.
  • Do not exceed roughly 2% until owner-earnings conversion, credit quality, and international economics are better documented.
  • Reduce these limits if the portfolio already has meaningful Kazakhstan, emerging-market financial, or currency exposure.

Add only when evidence improves

Increase the position if:

  1. Nonperforming loans, cost of risk, and reserve coverage remain controlled.
  2. Regulatory capital, funding costs, and liquidity remain sound.
  3. Earnings translate into dividends, repurchases, or demonstrably available capital.
  4. Organic ecosystem activity and segment profits grow without excessive incentives.
  5. U.S.-dollar earnings per share grow, not merely local-currency revenue.
  6. Acquired or international operations show improving unit economics and controlled capital consumption.

A broad market or country-driven decline could be an opportunity if these fundamentals remain intact. Do not average down merely because the multiple becomes lower.

Halt additions or reduce exposure if:

  • Credit losses rise materially or reserves become inadequate.
  • Funding or regulatory-capital pressure limits distributions.
  • Revenue grows while per-share profit and available capital stagnate.
  • Tenge depreciation persistently erodes U.S.-dollar owner value.
  • Regulation structurally compresses payment, commerce, or lending economics.
  • International expansion consumes increasing capital without improving returns.
  • Governance, sanctions, capital controls, or minority-shareholder treatment deteriorate.

Lessons Applied

The earlier KSPI mistake was allowing persistent background risks to produce excessive caution despite low valuation, strong profitability, and constructive market evidence. This time, those risks should reduce position size rather than prevent participation.

The GRAB lesson provides the necessary restraint: platform language and rapid growth are not sufficient when valuation is demanding and cash economics are weak. Kaspi is materially different because its profitability is already substantial and its valuation is compressed. Even so, owner earnings and incremental returns must be verified before increasing concentration.

Kaspi does not yet qualify for an unrestricted Buffett-style position. But the available evidence favors a real local franchise priced below a reasonable base estimate, with uncertainty that can be managed through staged purchases and strict portfolio limits.

ADVOCATE

Scorecard

Overall 3.85 out of 5, weighted as shown.

DimensionWeightScoreWhat it measures
Business Quality30%4.50 / 5High returns, profitability, and Piotroski health support durability.
Valuation Support30%4.33 / 5Blends current price against available intrinsic value anchors and valuation ratios.
Financial Strength20%3.00 / 5Balance-sheet resilience reflects leverage and liquidity staying within safe ranges.
Growth Durability20%3.00 / 5Recent revenue, earnings, and free cash flow growth indicate how durable expansion looks.

This briefing is from Oct 22, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Get the iPhone appGet the Android app

Margin of Safety Weekly

Every Saturday: the market’s temperature, what the great investors filed, and the week’s research.

Send me the DeepValues Margin of Safety Weekly, one email every Saturday. I can unsubscribe at any time. Information only, not investment advice. Privacy